+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Mammography Devices Market, By Product Type (Full-field Digital Mammography, Film-screen Mammogram, Breast Tomosynthesis), By Technology (Digital v/s Analog), By End User, By Country, Competition, Forecast & Opportunities, 2018-2028F

  • PDF Icon

    Report

  • 82 Pages
  • December 2022
  • Region: Asia Pacific
  • TechSci Research
  • ID: 5706810
Free Webex Call
10% Free customization

Increasing need for advanced technology for the early detection of breast cancer has significantly increased the demand for Mammography Devices across distinct parts of the Asia Pacific region

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Asia Pacific Mammography Devices Market is anticipated to witness impressive growth during the forecast period. It ascribes to the growing geriatric population across the region susceptible to breast cancer. Additionally, increasing need for advanced technology for the early detection of breast cancer has significantly increased the demand for Mammography Devices across distinct parts of the Asia Pacific region. Additionally, growing government reimbursement policies to avail the advanced healthcare procedure is expected to increase the demand for various Mammography Devices, fueling market growth through 2028. Besides, the rising adoption of advanced technology in countries like China and India and the availability of advanced methods are expected to support the Asia Pacific Mammography Devices market during the forecast period. Furthermore, growing lifestyle and nutritional changes are expected to increase the demand for mammography devices, thereby supporting market growth. Similarly, favorable government initiatives for the better treatment of breast cancer is expected to create a lucrative vgrowth during the forecast period. Besides, newly developed mammography device with lower cost will boost the market growth during the forecast period. In 2012, the disease affected 1.7 million women and caused over 522,000 deaths (WHO, 2017).

The increasing prevalence of breast Cancer propels the market growth

Increasing implementation of preventive healthcare and disease diagnosis programs can create lucrative growth in the market during the forecast period. Developing countries like Japan have taken the initiative in cancer control programs because it is one of Japan’s leading causes of death. So, cancer screening programs are xpected cted across the country by municipalities with government support. It, in turn, is expected to create lucrative growth over the years. Breast screen Australia, the government’s national screening program, invites women between 50-74 to undergo free mammograms every 2 years. Women aged 40-49 and those over 74 are screened free of charge. Increasing high prevalence in developing areas because of lifestyle changes among women who are engaged in the working class, and breast cancer peruse is one of the chronic diseases of urban women primarily. This can be an essential growth factor for the growth of the market during the forecast period.

Rising investment by the government in carcinoma therapy

Increasing beneficial government rules and policies for launching of new devices like Mammography Devices expects to create lucrative growth during the forecast period. Similarly, increasing awareness for the detection of breast cancer enhances the demand for Mammography devices across the region, this in turn boosts the market growth during the forecast period. The predicted age-standardized incidence rate of breast cancer in Asia is 34.4 per 100,000, according to GLOBOCAN 2018. Various organizations are investing in developing new technology for the treatment of breast cancer which will further boost the market growth during the forecast period. According to a 2018 report from the Centres for Disease Control and Prevention (CDCP), regardless of race or ethnicity, breast cancer is one of the most common cancers in women. Different non-governmental organizations, hospitals, and other public welfare organizations have taken initiative for organizing camps and awareness campaigns to spread awareness pertaining to breast cancer, these factors are expected to boost the market growth over the years.

Market Segmentation

The Asia Pacific Mammography Devices market can be segmented by product type, by technology, and region. Based on Product Type, the market can be segmented into Full-field Digital Mammography, Film-screen Mammogram, and Breast Tomosynthesis. Based on technology, the market can be divided into Digital and Analog. Based on end-user, the market can be grouped into Hospitals & Clinics, Diagnostic Centers, and Others. According to Statista in 2021, China’s breast imaging market was projected to be about 272 million U.S. dollars, accounting for roughly 6.5 percent of the global market.

Recent Development

For instance, in October 2021, FUJIFILM Canada Inc. received a Health Canada medical device license for its ASPIRE Cristalle digital mammography solution. It also expanded its partnership with Christie Innomed to offer the product across every province in Canada.

In December 2020, Hologic Inc received the product approval from US Food and Drug Administration their Company’s Genius AI Detection technology, a new deep learning-based software. This software helps in the early detection of breast cancer when used with the Genius 3D Mammography exam, as Genius AI Detection software aids in the identification and early detection of breast cancer.

In March 2020, Therapixel received the US FDA approval for their MammoScreen which is a computer-assisted detection and diagnosis software. This software helps the clinicians in identifying relevant findings when used with compatible full-field digital mammography systems.

Market Players

Siemens Healthineers AG, GE Healthcare (Smart Breast Corporation), Koninklijke Philips N.V., Canon Medical Systems Corporation, Fujifilm Holdings Corporation, Carestream Health, Inc., Delphinus Medical Technologies, Inc, Konica Minolta Inc, Hologic Inc., Planmed OY, Metaltronica SpA, IMS Giotto S.P.A, NP JSC Amico, Analogic Corporation, KUB Technologies Inc., are some of the leading players operating in the Asia Pacific Mammography Devices Market.

Report Scope:

In this report, the Asia Pacific Mammography Devices market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Asia Pacific Mammography Devices Market, By Product Type:

  • Full-field Digital Mammography
  • Film-screen Mammogram
  • Breast Tomosynthesis

Asia Pacific Mammography Devices Market, By Technology:

  • Digital
  • Analog

Asia Pacific Mammography Devices Market, By End User:

  • Hospitals & Clinics
  • Diagnostic Centers
  • Others

Asia Pacific Mammography Devices Market, By Country:

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Malaysia
  • Vietnam
  • Indonesia
  • Singapore

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present Asia Pacific Mammography Devices Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).



This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
4.1. Breast Cancer Prevalence, By Age Group
4.2. Breast Cancer Prevalence, By Country
4.3. Preferred Choice of Technology in Mammography Devices
4.4. Demand, By Product Type
5. Asia Pacific Mammography Devices Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value & Volume
5.2. Market Share & Forecast
5.2.1. By Product Type (Full-field Digital Mammography, Film-screen Mammogram, Breast Tomosynthesis)
5.2.2. By Technology (Digital v/s Analog)
5.2.3. By End User (Hospitals & Clinics, Diagnostic Centers, Others)
5.2.4. By Region
5.2.5. By Company (2022)
5.3. Product Market Map
6. China Mammography Devices Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By Technology
6.2.3. By End User
6.3. Pricing Analysis
7. India Mammography Devices Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Technology
7.2.3. By End User
7.3. Pricing Analysis
8. Japan Mammography Devices Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Technology
8.2.3. By End User
8.3. Pricing Analysis
9. South Korea Mammography Devices Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Technology
9.2.3. By End User
9.3. Pricing Analysis
10. Australia Mammography Devices Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value & Volume
10.2. Market Share & Forecast
10.2.1. By Product Type
10.2.2. By Technology
10.2.3. By End User
10.3. Pricing Analysis
11. New Zealand Mammography Devices Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value & Volume
11.2. Market Share & Forecast
11.2.1. By Product Type
11.2.2. By Technology
11.2.3. By End User
11.3. Pricing Analysis
12. Malaysia Mammography Devices Market Outlook
12.1. Market Size & Forecast
12.1.1. By Value & Volume
12.2. Market Share & Forecast
12.2.1. By Product Type
12.2.2. By Technology
12.2.3. By End User
12.3. Pricing Analysis
13. Vietnam Mammography Devices Market Outlook
13.1. Market Size & Forecast
13.1.1. By Value & Volume
13.2. Market Share & Forecast
13.2.1. By Product Type
13.2.2. By Technology
13.2.3. By End User
13.3. Pricing Analysis
14. Indonesia Mammography Devices Market Outlook
14.1. Market Size & Forecast
14.1.1. By Value & Volume
14.2. Market Share & Forecast
14.2.1. By Product Type
14.2.2. By Technology
14.2.3. By End User
14.3. Pricing Analysis
15. Singapore Mammography Devices Market Outlook
15.1. Market Size & Forecast
15.1.1. By Value & Volume
15.2. Market Share & Forecast
15.2.1. By Product Type
15.2.2. By Technology
15.2.3. By End User
15.3. Pricing Analysis
16. Market Dynamics
16.1. Drivers
16.2. Challenges
17. Market Trends & Developments
17.1. Recent Developments
17.2. Mergers & Acquisitions
17.3. Product Launches
18. Asia Pacific Mammography Devices Market: SWOT Analysis
19. Competitive Landscape
19.1. Business Overview
19.2. Product Offerings
19.3. Recent Developments
19.4. Financials (As Reported)
19.5. Key Personnel
19.6. SWOT Analysis
19.6.1. Siemens Healthineers AG
19.6.2. GE Healthcare (Smart Breast Corporation)
19.6.3. Koninklijke Philips N.V.
19.6.4. Canon Medical Systems Corporation
19.6.5. Fujifilm Holdings Corporation
19.6.6. Carestream Health, Inc.
19.6.7. Delphinus Medical Technologies, Inc
19.6.8. Konica Minolta Inc
19.6.9. Hologic Inc.
19.6.10. Planmed OY
19.6.11. Metaltronica SpA
19.6.12. IMS Giotto S.P.A
19.6.13. NP JSC Amico
19.6.14. Analogic Corporation
19.6.15. KUB Technologies Inc.
20. Strategic Recommendations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Siemens Healthineers AG
  • GE Healthcare (Smart Breast Corporation)
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • Fujifilm Holdings Corporation
  • Carestream Health, Inc.
  • Delphinus Medical Technologies, Inc
  • Konica Minolta Inc
  • Hologic Inc.
  • Planmed OY
  • Metaltronica SpA
  • IMS Giotto S.P.A
  • NP JSC Amico
  • Analogic Corporation
  • KUB Technologies Inc.